Tattoo aftercare, maintenance
Tattoo Goo recently introduced an incremental traffic-driving opportunity with its body art aftercare kit of the same name. Tattoos no longer are taboo as more than 12 million adults sport permanent body art, including 25% of those between the ages of 30 and 39 years, and 12% of those between the ages of 40 and 49 years.
Today’s aftercare protocol has the recently inked reaching for A+D ointment. But Tattoo Goo, which estimates the total market may exceed $100 million, fields not only its aftercare regimen but also a maintenance oil to prevent fading.
The article above is part of the DSN Category Review Series. For the complete First Aid Sell-Through Report, including extensive charts, data and more analysis, click here.
Q&A: Prestige-ous plan
Prestige Brands earlier this year completed its acquisition of 17 GlaxoSmithKline brands. Drug Store News sat with Prestige SVP sales and marketing Tim Connors to discuss what’s next.
DSN: What is the next step?
Tim Connors: Our strategic value creation plan consists of three components:
- Grow our brands organically;
- Acquire [additional] OTC brands; and
- Strategically manage our portfolio.
That’s our roadmap to becoming a $1 billion OTC company.
DSN: What are some of the synergies that you see coming out of Prestige’s broader portfolio.
Connors: The real benefit from having an expanded brand portfolio, simply put, [is] the shared knowledge across our brand portfolios in analgesics, gastrointestinal, cough-cold, ear-eye, oral care, sleep aids, dermatology and household. Developing and sharing consumer insights, new product development technologies, class of trade expertise and a deeper knowledge of the consumer are the most important building blocks for our brands long term.
DSN: Can you provide an example?
Connors: Dramamine. … We [uncovered] a consumer insight that moms use the [adult] product for their kids. … So we came out with a new Dramamine for Kids with a lower dose that would be applicable for children under 13 [years of age].
Vitamins continue growth
Sales of vitamins, totaling almost $3.6 billion, were up 2.7% for the 52 weeks ended May 13, according to SymphonyIRI Group data across food drug and mass (excluding Walmart).
And according to a recent TABS Group analysis, that growth came despite the percentage of U.S. vitamin users in 2012 decreasing from 71% to 66% — trade-ups, price inflation and the increased use emanating from current buyers purchasing more vitamins were the drivers behind today’s growth, said Kurt Jetta, TABS Group CEO.
The steep growth curves representing fish oil and vitamin D sales may be plateauing, Jetta added. But vitamin B and energy remains on a strong growth curve.
Pharmavite recently pulled out all the stops in flowing innovation through mass market supplements. The company launched a line of VitaMelts with six initial SKUs, offering a dissolvable tablet format that doesn’t require water. Also for the pill fatigued, Pharmavite will be replacing many of its Nature Made soft gel brands with Full Strength Minis that feature similar supplement formulations in a softgel that is between 28% and 42% smaller.
Pharmavite also launched a full adult gummies line and introduced Voots, a pediatric supplement that packs the punch of three servings of fruits and vegetables.
The article above is part of the DSN Category Review Series. For the complete Vitamins, Minerals and Supplements Buy-In Report, including extensive charts, data and more analysis, click here.